Extracellular vesicles modified ex vivo as an anti-cancer immune-response boosting vaccine
2021/41/N/NZ6/02682
Keywords
Descriptors
- NZ6_002: Immunologia kliniczna
- NZ6_001: Odporność swoista i nieswoista
- NZ5_007: Leczenie chorób człowieka
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 20 – announced on 2021-03-15
- Amount awarded
- 209 936 PLN
- Project start date
- 2022-01-11
- Project end date
- 2026-01-10
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
MiR-128-3p - a gray eminence of the human central nervous system
- Authors:
- Klaudia Kiel, Sylwia Katarzyna Król, Agnieszka Bronisz, Jakub Godlewski
- Academic press:
- Molecular Therapy Nucleic Acids (year: 2024, volume: 35 (1), pages: 102141), Publisher: Cell Press
- Status:
- Published
- DOI:
- 10.1016/j.omtn.2024.102141 – link to the publication